Companies › JAGX
Jaguar Health Inc (JAGX)
Institutional ownership, SEC filings and insider activity
Sector: Healthcare & Pharma · SEC CIK 0001585608 · EDGAR filings · Updated 2026-07-27
Jaguar Health Inc (JAGX) has reported institutional ownership of 49.8%, with 11 institutional managers holding positions valued at $94.2K per the latest 13F reporting period. SEC filings include an active notice of delisting or failure to satisfy a continued listing rule (8-K Item 3.01), substantial-doubt (going concern) disclosure per the filings.
Filings this week (6)
- 2026-07-27 — Prospectus supplement (424B3) filed
- 2026-07-27 — Prospectus supplement (424B3) filed
- 2026-07-24 — EFFECT filed
- 2026-07-24 — EFFECT filed
- 2026-07-24 — PRE 14A filed
- 2026-07-24 — S-1/A filed
Every filing links to the official SEC document. Real-time filing alerts for this company are available inside the app.
Institutional ownership overview
According to SEC 13F filings tracked by Sightfile, Jaguar Health Inc has 11 institutional holders and institutional ownership of 49.8%.
Insider activity
Insiders reported 11 transactions (0 buys, 0 sells) across 10 reporting insiders, with a net reported value of $0.
Data flags from SEC filings
Related companies
Glucotrack Inc (GCTK) · Catheter Precision Inc (VTAK) · AIM IMMUNOTECH INC (AIM) · Lifeward Inc (LFWD) · Co-Diagnostics Inc (CODX) · PLURI INC (PLUR)
See full history, cross-references and alerts on SightfileData sources: SEC EDGAR (filings, 13F, FTD), aggregated by Sightfile. Page updated 2026-07-27.